Back to Scalp Care latest news
The Beauty MonitorScalp Care

Biotech Actives And Bold Growth Claims Reset The Scalp Serum Category

15 November 2026by Beauty Monitor AI
Biotech Actives And Bold Growth Claims Reset The Scalp Serum Category

Analysis

The week's most significant development for the premium scalp category is a claims story. Dermatologist-founded scalp health and hair growth brand KilgourMD unveiled a full brand relaunch on 12 November, including reformulated versions of its best-selling scalp serums built around proprietary biotech actives [1]. The relaunch arrives with new packaging and a headline 172 per cent "hair growth" claim, which trade coverage has examined against the underlying data [2]. For brand and retail teams, the interest is less in the number itself than in the precedent: percentage growth claims of that magnitude invite scrutiny of trial design and substantiation, and set the benchmark buyers will apply to the next serum pitched to them.

Ingredient innovation is moving in parallel, and towards comfort rather than growth. TRI-K used in-cosmetics Asia to debut TRIglyphix Soothe, an active designed to help formulators address sensitive scalp needs with visible benefits and a stated focus on lasting comfort [3]. That positioning maps onto the itching, tightness and redness that quality titles now treat as the defining scalp complaints, alongside continued editorial interest in salicylic acid as a gentle purifying route in anti-dandruff formats [4]. Scepticism about naturals persists: Vogue has again pressed whether rosemary, castor and pumpkin seed oils actually do anything for thinning hair [5].

UK demand signals remain weighted towards medicalised solutions. Over the past three months 'minoxidil' averaged 53/100 search interest, reading 42/100 in the week of 9 November, far ahead of 'dandruff shampoo' at 10/100 and 'hair loss treatment' at 6/100 [6][7][8]. Device content is comparatively thin, with recent iRestore laser review uploads totalling only 2,797 views [9].

Key Themes

scalp serumsclaim substantiationbiotech activessensitive scalpminoxidil demand